28 filings
8-K
Arrogene, Inc
6 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
Arrogene, Inc
19 May 16
Unregistered Sales of Equity Securities
12:00am
8-K
Arrogene, Inc
12 May 16
Entry into a Material Definitive Agreement
12:00am
8-K
Arrogene, Inc
21 Apr 16
Unregistered Sales of Equity Securities
12:00am
8-K
Arrogene, Inc
21 Jan 16
Unregistered Sales of Equity Securities
12:00am
8-K
hbnqi3zoh02d4bjy
29 Aug 14
Departure of Directors or Certain Officers
12:00am
8-K
0u3xyn tb5
3 Jul 14
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
q7g7429p
5 May 14
Unregistered Sales of Equity Securities
12:00am
8-K
3bhjkflblrxr
24 Apr 14
Unregistered Sales of Equity Securities
12:00am
8-K
ddy5xtdr9u7vm
7 Apr 14
Unregistered Sales of Equity Securities
12:00am
8-K
qbnos1kkneab
7 Mar 14
Unregistered Sales of Equity Securities
12:00am
8-K
uog pj6x6jawpfryz
22 Aug 13
Other Events
12:00am
8-K
1u5kiskfy2743k
27 Feb 13
Unregistered Sales of Equity Securities
12:00am
8-K
j1qh8vwxv7 c5y7v9ap
11 Dec 12
Unregistered Sales of Equity Securities
12:00am
8-K
t3pgq9nb
11 Dec 12
Unregistered Sales of Equity Securities
12:00am
8-K
92wacuhy mbcrpt
16 Oct 12
Arrogene presents breakthrough nanobioplatform at the 11th Annual BIO Investor Forum
12:00am
8-K
h4e5pl 76f85d
10 Sep 12
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K/A
86tpkcq13 7fyyhx
24 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
58h44ycy1n2o5
19 Jul 12
Unregistered Sales of Equity Securities
12:00am
8-K
vzifby xj
21 Jun 12
Arrogene’s Innovative Multi-target Nano-platform for Cancer Therapeutics to Be Discussed at the 2012 Techconnect World Nanotechnology Conference
12:00am